IOHEXOL , Placebo to match LY3437943, Retatrutide
J1I-MC-GZBU
Phase 2 small_molecule active
Quick answer
IOHEXOL , Placebo to match LY3437943, Retatrutide for Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active